AMPD2 | Adenosine monophosphate deaminase 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | Predicted intracellular proteins
| | | | | Expressed in all |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
C21orf59 | Chromosome 21 open reading frame 59 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DDX3X | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ECH1 | Enoyl CoA hydratase 1, peroxisomal | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IER5 | Immediate early response 5 | Predicted intracellular proteins
| | | | | Expressed in all |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
KMT2E | Lysine (K)-specific methyltransferase 2E | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LIAS | Lipoic acid synthetase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
LRPAP1 | Low density lipoprotein receptor-related protein associated protein 1 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
MARS | Methionyl-tRNA synthetase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
NDUFV2 | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
NECAB2 | N-terminal EF-hand calcium binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NEFL | Neurofilament, light polypeptide | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
OGFOD1 | 2-oxoglutarate and iron-dependent oxygenase domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PBK | PDZ binding kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
QKI | QKI, KH domain containing, RNA binding | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
RABGGTB | Rab geranylgeranyltransferase, beta subunit | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
RAD18 | RAD18 E3 ubiquitin protein ligase | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
RAP1GAP | RAP1 GTPase activating protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
RCN2 | Reticulocalbin 2, EF-hand calcium binding domain | Predicted secreted proteins
| | | | | Expressed in all |
RPL9 | Ribosomal protein L9 | Plasma proteins Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |
SAYSD1 | SAYSVFN motif domain containing 1 | Predicted membrane proteins
| | | | | Expressed in all |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SSR3 | Signal sequence receptor, gamma (translocon-associated protein gamma) | Predicted membrane proteins
| | | | | Expressed in all |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SYNJ2BP | Synaptojanin 2 binding protein | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
SYNJ2BP-COX16 | SYNJ2BP-COX16 readthrough | Predicted intracellular proteins
| | | | | Mixed |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
TXNL1 | Thioredoxin-like 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |